{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T14:45:10Z","timestamp":1791297910111,"version":"4.1.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2013,4,1]],"date-time":"2013-04-01T00:00:00Z","timestamp":1364774400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,4,1]],"date-time":"2013-04-01T00:00:00Z","timestamp":1364774400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2013,1,28]],"date-time":"2013-01-28T00:00:00Z","timestamp":1359331200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/3.0\/"}],"funder":[{"name":"MassBiologics, University of Massachusetts","award":["UL1TR000067"],"award-info":[{"award-number":["UL1TR000067"]}]},{"name":"NIH","award":["DK078772"],"award-info":[{"award-number":["DK078772"]}]}],"content-domain":{"domain":["amjtransplant.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Transplantation"],"published-print":{"date-parts":[[2013,4]]},"DOI":"10.1111\/ajt.12083","type":"journal-article","created":{"date-parts":[[2013,1,28]],"date-time":"2013-01-28T13:27:03Z","timestamp":1359379623000},"page":"1047-1054","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":84,"title":["Human Monoclonal Antibody MBL-HCV1 Delays HCV Viral Rebound Following Liver Transplantation: A Randomized Controlled Study"],"prefix":"10.1016","volume":"13","author":[{"given":"R.T.","family":"Chung","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.D.","family":"Gordon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.P.","family":"Curry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.D.","family":"Schiano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Emre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Corey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.F.","family":"Markmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Hertl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.J.","family":"Pomposelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.A.","family":"Pomfret","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Florman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Schilsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.J.","family":"Broering","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.W.","family":"Finberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Szabo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.D.","family":"Zamore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"U.","family":"Khettry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.J.","family":"Babcock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.M.","family":"Ambrosino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Leav","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Leney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.L.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.C.","family":"Molrine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl 1","key":"10.1111\/ajt.12083_bib1","first-page":"1","article-title":"Organ Procurement and Transplantation Network and Scientific Registry of Transplant Recipients 2010 data report","volume":"12","year":"2012","journal-title":"Am J Transplant"},{"key":"10.1111\/ajt.12083_bib2","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.1002\/lt.21954","article-title":"Natural history of post-liver transplantation hepatitis C: A review of factors that may influence its course","volume":"15","author":"Gallegos-Orozco","year":"2009","journal-title":"Liver Transpl"},{"key":"10.1111\/ajt.12083_bib3","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1053\/j.gastro.2012.02.011","article-title":"Viral hepatitis in liver transplantation","volume":"142","author":"Crespo","year":"2012","journal-title":"Gastroenterology"},{"key":"10.1111\/ajt.12083_bib4","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1002\/lt.22271","article-title":"PHOENIX: A randomized controlled trial of peginterferon alfa-2a plus ribavirin as a prophylactic treatment after liver transplantation for hepatitis C virus","volume":"17","author":"Bzowej","year":"2011","journal-title":"Liver Transpl"},{"key":"10.1111\/ajt.12083_bib5","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1053\/j.gastro.2007.03.041","article-title":"Efficacy of antiviral therapy on hepatitis C recurrence after liver transplantation: A randomized controlled study","volume":"132","author":"Carrion","year":"2007","journal-title":"Gastroenterology."},{"key":"10.1111\/ajt.12083_bib6","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1056\/NEJM199311183292102","article-title":"Prophylactic administration of respiratory syncytial virus immune globulin to high-risk infants and young children. The Respiratory Syncytial Virus Immune Globulin Study Group","volume":"329","author":"Groothuis","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1111\/ajt.12083_bib7","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/j.idc.2011.07.005","article-title":"Polyclonal immunoglobulins and hyperimmune globulins in prevention and management of infectious diseases","volume":"25","author":"Hsu","year":"2011","journal-title":"Infect Dis Clin North Am"},{"key":"10.1111\/ajt.12083_bib8","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1093\/infdis\/156.1.56","article-title":"Prevention of endemic icteric viral hepatitis by administration of immune serum gamma globulin","volume":"156","author":"Conrad","year":"1987","journal-title":"J Infect Dis"},{"issue":"5 Pt 1","key":"10.1111\/ajt.12083_bib9","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1016\/S0016-5085(77)80208-4","article-title":"Development of chronic liver disease after acute non-A, non-B post-transfusion hepatitis. Role of gamma-globulin prophylaxis in its prevention","volume":"72","author":"Knodell","year":"1977","journal-title":"Gastroenterology"},{"key":"10.1111\/ajt.12083_bib10","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1001\/archinte.1997.00440350037004","article-title":"Sexual transmission of the hepatitis C virus and efficacy of prophylaxis with intramuscular immune serum globulin. A randomized controlled trial","volume":"157","author":"Piazza","year":"1997","journal-title":"Arch Intern Med"},{"key":"10.1111\/ajt.12083_bib11","doi-asserted-by":"crossref","first-page":"6023","DOI":"10.1128\/JVI.79.10.6023-6034.2005","article-title":"Human serum facilitates hepatitis C virus infection, and neutralizing responses inversely correlate with viral replication kinetics at the acute phase of hepatitis C virus infection","volume":"79","author":"Lavillette","year":"2005","journal-title":"J Virol"},{"key":"10.1111\/ajt.12083_bib12","doi-asserted-by":"crossref","first-page":"6025","DOI":"10.1073\/pnas.0607026104","article-title":"Rapid induction of virus-neutralizing antibodies and viral clearance in a single-source outbreak of hepatitis C","volume":"104","author":"Pestka","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1111\/ajt.12083_bib13","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1097\/00000658-200205000-00002","article-title":"New era of liver transplantation for hepatitis B: A 17-year single-center experience","volume":"235","author":"Anselmo","year":"2002","journal-title":"Ann Surg"},{"key":"10.1111\/ajt.12083_bib14","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1111\/j.1600-6143.2010.03046.x","article-title":"Impact of virologic breakthrough and HBIG regimen on hepatitis B recurrence after liver transplantation","volume":"10","author":"Degertekin","year":"2010","journal-title":"Am J Transplant"},{"key":"10.1111\/ajt.12083_bib15","doi-asserted-by":"crossref","first-page":"2571","DOI":"10.1016\/S0041-1345(01)02101-7","article-title":"Use of combination cytomegalovirus immune globulin plus ganciclovir for prophylaxis in CMV-seronegative liver transplant recipients of a CMV-seropositive donor organ: A multicenter, open-label study","volume":"33","author":"Snydman","year":"2001","journal-title":"Transplant Proc"},{"key":"10.1111\/ajt.12083_bib16","doi-asserted-by":"crossref","first-page":"810","DOI":"10.7326\/0003-4819-128-10-199805150-00003","article-title":"Incidence of hepatitis C in patients receiving different preparations of hepatitis B immunoglobulins after liver transplantation","volume":"128","author":"Feray","year":"1998","journal-title":"Ann Intern Med"},{"key":"10.1111\/ajt.12083_bib17","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1002\/lt.20405","article-title":"A randomized, open-label study to evaluate the safety and pharmacokinetics of human hepatitis C immune globulin (Civacir) in liver transplant recipients","volume":"11","author":"Davis","year":"2005","journal-title":"Liver Transpl"},{"key":"10.1111\/ajt.12083_bib18","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1002\/lt.20876","article-title":"Monoclonal antibody HCV-AbXTL68 in patients undergoing liver transplantation for HCV: Results of a phase 2 randomized study","volume":"12","author":"Schiano","year":"2006","journal-title":"Liver Transpl"},{"key":"10.1111\/ajt.12083_bib19","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1002\/lt.20889","article-title":"Hepatitis C immune globulin to prevent HCV recurrence after liver transplantation: chasing windmills?","volume":"12","author":"Davis","year":"2006","journal-title":"Liver Transpl"},{"key":"10.1111\/ajt.12083_bib20","doi-asserted-by":"crossref","first-page":"12473","DOI":"10.1128\/JVI.01138-09","article-title":"Identification and characterization of broadly neutralizing human monoclonal antibodies directed against the E2 envelope glycoprotein of hepatitis C virus","volume":"83","author":"Broering","year":"2009","journal-title":"J Virol"},{"key":"10.1111\/ajt.12083_bib21","doi-asserted-by":"crossref","first-page":"e1002895","DOI":"10.1371\/journal.ppat.1002895","article-title":"Human monoclonal antibody HCV1 effectively prevents and treats HCV infection in chimpanzees","volume":"8","author":"Morin","year":"2012","journal-title":"PLoS Pathogens"},{"key":"10.1111\/ajt.12083_bib22","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1002\/hep.510250328","article-title":"Banff schema for grading liver allograft rejection: An international consensus document","volume":"25","year":"1997","journal-title":"Hepatology"},{"key":"10.1111\/ajt.12083_bib23","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1002\/hep.1840010511","article-title":"Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis","volume":"1","author":"Knodell","year":"1981","journal-title":"Hepatology"},{"key":"10.1111\/ajt.12083_bib24","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1053\/jhep.2002.31773","article-title":"Hepatitis C virus kinetics during and immediately after liver transplantation","volume":"35","author":"Garcia-Retortillo","year":"2002","journal-title":"Hepatology"},{"key":"10.1111\/ajt.12083_bib25","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1002\/lt.20572","article-title":"Kinetics of hepatitis C virus reinfection after liver transplantation","volume":"12","author":"Powers","year":"2006","journal-title":"Liver Transpl"},{"key":"10.1111\/ajt.12083_bib26","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1002\/lt.20206","article-title":"Evolution of hepatitis C virus quasispecies immediately following liver transplantation","volume":"10","author":"Feliu","year":"2004","journal-title":"Liver Transpl"},{"key":"10.1111\/ajt.12083_bib27","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1084\/jem.20090766","article-title":"Viral entry and escape from antibody-mediated neutralization influence hepatitis C virus reinfection in liver transplantation","volume":"207","author":"Fafi-Kremer","year":"2010","journal-title":"J Exp Med"},{"key":"10.1111\/ajt.12083_bib28","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1053\/j.gastro.2012.04.006","article-title":"Mutations that alter use of hepatitis C virus cell entry factors mediate escape from neutralizing antibodies","volume":"143","author":"Fofana","year":"2012","journal-title":"Gastroenterology"},{"key":"10.1111\/ajt.12083_bib29","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1002\/hep.24262","article-title":"Treatment failure and resistance with direct-acting antiviral drugs against hepatitis C virus","volume":"53","author":"Pawlotsky","year":"2011","journal-title":"Hepatology"},{"key":"10.1111\/ajt.12083_bib30","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1053\/j.gastro.2007.02.037","article-title":"Dynamic hepatitis C virus genotypic and phenotypic changes in patients treated with the protease inhibitor telaprevir","volume":"132","author":"Sarrazin","year":"2007","journal-title":"Gastroenterology"}],"container-title":["American Journal of Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fajt.12083","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fajt.12083","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1600613522259103?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1600613522259103?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/ajt.12083\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T04:59:20Z","timestamp":1761627560000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1600613522259103"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,4]]},"references-count":30,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013,4]]}},"alternative-id":["S1600613522259103"],"URL":"https:\/\/doi.org\/10.1111\/ajt.12083","relation":{},"ISSN":["1600-6135"],"issn-type":[{"value":"1600-6135","type":"print"}],"subject":[],"published":{"date-parts":[[2013,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Human Monoclonal Antibody MBL-HCV1 Delays HCV Viral Rebound Following Liver Transplantation: A Randomized Controlled Study","name":"articletitle","label":"Article Title"},{"value":"American Journal of Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1111\/ajt.12083","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 American Society of Transplantation & American Society of Transplant Surgeons. Published by Elsevier Inc. All rights reserved. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}